• Conference Proceeding

A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy

Citation

D'Ausilio, A., Aiello, A., Daniel, F., Graham, C., Roccia, A., & Toumi, M. (2015). A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy. In [18], p. A424. .

Abstract